main content start

Pagina inicial

Continue Watching

Últimos vídeos

Últimos vídeos

Brightcove Home Latest Listing

Oncology

Oncology

Brightcove Cards Listing

Hematology

Hematology

Brightcove Cards Listing

Popular em MedEnrich

Popular em MedEnrich

Popular in Sem nome
  • Mieloma múltiplo11m 40s

    How I Treat Relapsed Refractory Multiple Myeloma

    Treating relapsed or refractory multiple myeloma (RRMM) can be complex and typically involves a combination of therapies based on the patient's previous treatments, overall health, and specific disease characteristics.
    relapsed refractory multiple myeloma treatment combination treatment
  • Myelodysplastic Syndromes17m 28s

    A evolução do hipometilantes de DNA ao longo do tempo no tratamento da SMD/LMA e o papel da mutação TP53

    Assista a uma vídeo aula que aborda a evolução dos hipometilantes de DNA ao longo do tempo no tratamento da SMD/LMA e o papel da mutação TP53
    sdm lma hipometilantes dna tp53 ronald ronald feitosa ronald feitosa pinheiro
  • Oncology21m 26s

    Perspectivas do uso da carmustina nos gliomas

    Vídeo gravado durante evento de lançamento da Carmustina pela Dr. Reddy's, realizado na cidade de São Paulo, para uma audiência de oncologistas.
    tumores cerebrais glioblastoma
  • Myelodysplastic Syndromes8m 45s

    Current Challenges in MDS Diagnosis and Consequences

    Bone marrow examination-based diagnosis of MDS with either biopsy or aspirate remains standard of care but is associated with pain, bleeding, difficulty to use the same in elderly patients and hIgh interobserver variability.
    non invasive mds diagnosis web based mds diagnosis tools
  • 14m 46s

    ESMO 2022 Breast Cancer Comprehensive Coverage

    View comprehensive coverage of Breast Cancer from ESMO 2022
    dose dense adjuvant chemotherapy esmo keynote -522 monarch -3 study
  • 15m 43s

    Treatment sequencing - integrating CDK4-6 inhibitors with hormonal therapy in HR+ve ,Her2 Negative Metastatic Breast Cancer

    CDK4/6 inhibitors, combined with hormonal therapy, are key in treating HR+/HER2- metastatic breast cancer. Treatment sequencing after progression focuses on personalized strategies, including SERDs, PI3K/mTOR inhibitors, and chemotherapy.
    cdk4/6 inhibitors hormonal therapy personalized treatment strategies treatment sequencing
  • 14m 46s

    ESMO 2022 Breast Cancer Comprehensive Coverage

    View comprehensive coverage of Breast Cancer from ESMO 2022
    dose dense adjuvant chemotherapy esmo keynote -522 monarch -3 study
  • Myelodysplastic Syndromes3m 18s

    Anemia of MDS

    Anemia is common feature of MDS with 90% patients having anemia at diagnosis or initial presentation. Anemia not only impacts quality of life but is also prognostic in nature.
    anemia mds transfusion dependence
  • 15m 43s

    Treatment sequencing - integrating CDK4-6 inhibitors with hormonal therapy in HR+ve ,Her2 Negative Metastatic Breast Cancer

    CDK4/6 inhibitors, combined with hormonal therapy, are key in treating HR+/HER2- metastatic breast cancer. Treatment sequencing after progression focuses on personalized strategies, including SERDs, PI3K/mTOR inhibitors, and chemotherapy.
    cdk4/6 inhibitors hormonal therapy personalized treatment strategies treatment sequencing
  • Farmacia23m 30s

    Avaliação de novas terapias e seu impacto da teoria à prática

    Avaliação de novas terapias é um processo complexo que necessita de atuação interdisciplinar para sua execução.
    farmacêutico oncologia teoria prática
  • Webinar passado

    Webinar Cards Listing

    MedBytes

    MedBytes

    Medbytes Cards Listing
    Hola, ¿puedo ayudar?
    Suporte por bate-papoX
    Equipe de suporte
    Hola, ¿cómo puedo ayudarlo hoy?
    Seleccione una de las siguientes opciones.

    Buscar información

    No puedo iniciar sesión o registrarse

    compartilhar comentarios